Importantly, BFL1 mutants that escape ubiquitin‐mediated proteasomal degradation are more stable and accelerate tumour formation in the presence of a dominant negative, truncated version of p53DD16, indicating the importance of BFL1 expression levels for facilitating tumour formation. Here, BCL2A1 is linked to neoplasm.